Histopathological analysis and in situ localisation of Australian tiger snake venom in two clinically envenomed domestic animals by Jacoby-Alner, T.E. et al.
 
 
MURDOCH RESEARCH REPOSITORY 
 
 
 
 
This is the author’s final version of the work, as accepted for publication  
following peer review but without the publisher’s layout or pagination.  
The definitive version is available at 
http://dx.doi.org/10.1016/j.toxicon.2011.07.008  
 
 
Jacoby-Alner, T.E., Stephens, N., Davern, K.M., Balmer, L., 
Brown, S.G.A. and Swindells, K. (2011) Histopathological 
analysis and in situ localisation of Australian tiger snake venom 
in two clinically envenomed domestic animals. Toxicon,  
58 (4). pp. 304-314. 
 
 
 
 
http://researchrepository.murdoch.edu.au/5338/ 
 
 
 
 
Copyright: © 2011 Elsevier Ltd. 
 
It is posted here for your personal use. No further distribution is permitted. 
 
 
 Accepted Manuscript
Title: Histopathological analysis and in situ localisation of Australian tiger snake
venom in two clinically envenomed domestic animals
Authors: T.E. Jacoby-Alner, N. Stephens, K.M. Davern, L. Balmer, S.G.A. Brown, K.
Swindells
PII: S0041-0101(11)00226-1
DOI: 10.1016/j.toxicon.2011.07.008
Reference: TOXCON 4145
To appear in: Toxicon
Received Date: 23 March 2011
Revised Date: 8 July 2011
Accepted Date: 12 July 2011
Please cite this article as: Jacoby-Alner, T.E., Stephens, N., Davern, K.M., Balmer, L., Brown, S.G.A.,
Swindells, K. Histopathological analysis and in situ localisation of Australian tiger snake venom in two
clinically envenomed domestic animals, Toxicon (2011), doi: 10.1016/j.toxicon.2011.07.008
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.MANUSCRIPT
 
ACCEPTED
ACCEPTED MANUSCRIPT
Histopathological analysis and in situ localisation of Australian tiger snake venom  
in two clinically envenomed domestic animals  
Jacoby-Alner, T.E.
1,2, Stephens, N.
3, Davern, K.M. 
2, Balmer, L.
4,  Brown, S.G.A.
5  and Swindells, K.
6  
Highlights 
  Venom-induced pathological changes were observed in the lungs, kidneys and muscle 
tissue of both patients 
  Evidence, not previously noted, of procoagulant venom effects were apparent, with 
formed thrombi in the heart, lungs (small fibrillar aggregates and larger, discrete 
thrombi) and kidneys 
  Work has shown pathological evidence of procoagulant venom activity supporting 
previous suggestions that an initial thrombotic state occurs in envenomed patients 
  Illustrates venom localisation in the lung, kidney and muscle tissues of clinically 
envenomed animals 
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Abstract 
Objective: To assess histopathological changes in clinically envenomed tiger snake patients and 
identify tissue specific localisation of venom toxins using immunohistochemistry. 
Samples: One feline and one canine patient admitted to the Murdoch Pet Emergency Centre 
(MPEC), Murdoch University with tiger snake (Notechis sp.) envenoming. Both patients died as a 
result of envenomation. Non-envenomed tissue was also collected and used for comparison. 
Methodology:  Biopsy samples (heart, lung, kidney and  skeletal muscle tissue) were retrieved 1-2 
hours post death and processed for histopathological examination using Haemotoxylin and Eosin, 
Martius Scarlet Blue and Periodic Acid Schiff  staining. Tissues were examined by light 
microscopy and tissue sections subjected to immunohistochemical staining using in-house 
generated monoclonal and polyclonal antibodies against Notechis venoms.  
Results: Venom-induced pathological changes were observed in the lungs, kidneys and muscle 
tissue of both patients. Evidence, not previously noted, of procoagulant venom effects were 
apparent, with formed thrombi in the heart, lungs (small fibrillar aggregates and larger, discrete 
thrombi) and kidneys. Immunohistochemical assays revealed venom present in the pulmonary 
tissue, in and around the glomerular capsule and surrounding tubules in renal tissue and scattered 
throughout the Gastrocnemius muscle tissue. 
Conclusion: This work has shown pathological evidence of procoagulant venom activity 
supporting previous suggestions that an initial thrombotic state occurs in envenomed patients. We 
have shown that venom toxins are able to be localised to specific tissues, in this case, venom was 
detected in the lung, kidney and muscle tissues of clinically envenomed animals. Future work will 
examine specific toxin localisation using monoclonal antibodies and identify if antivenom 
molecules are able to reach their target tissues.  
Keywords: Tiger snake, Notechis scutatus, snake bite, envenoming, immunohistochemistry, 
histopathology. 
Abbreviations: VICC: Venom-induced consumptive coagulopathy, Nsv: Notechis scutatus venom, 
PBS: Phosphate buffered saline, FBS: Fetal bovine serum, IHC: Immunohistochemistry, CK: 
Creatine kinase, MPEC: Murdoch Pet Emergency Centre, VDK: Venom detection kit, GM: 
Gastrocnemius muscle, H&E: Haemotoxylin and Eosin, MSB: Martius Scarlet Blue, PAS: MANUSCRIPT
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Periodic Acid Schiff, AV: antivenom, OCT: Optimal cutting temperature, APTT: Activated partial 
thromboplastin time. 
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1.  Introduction 
There are up to 3,000 reported snakebites in humans (Sutherland and Leonard 1995; White 2000) 
and an estimated 6,000 snakebites in domestic animals each year in Australia (Mirtschin et al. 
1998), many requiring antivenom (AV) treatment. The most common, potentially lethal clinical 
feature seen in envenomed humans is venom-induced consumptive coagulopathy (VICC); a result 
of procoagulant toxins in the venom. The severity and occurrence of major clinical effects seen in 
human and animal victims appears to differ. As shown by Isbister et al., (2008) (Isbister et al. 
2008), 90% of human tiger snake bite patients display VICC, with few presenting with neurotoxic 
and myotoxic effects. In contrast, canine victims present more often with paralysis, though may 
also present with clinical signs referrable to coagulopathy  (Holloway and Parry 1989). This may 
be a reflection of differences in time since bite to discovery and treatment in the two groups and 
that VICC may go unnoticed in animals. It is not uncommon for domestic animal envenomings to 
be discovered hours, sometimes days after the bite or when symptoms are observed, whereas 
envenomed humans are almost always noticed at the time of first aid investigation, with  treatment 
following  shortly  thereafter.  Cats  rarely  have  clinical  signs  of  coagulopathy  but  show  severe 
paralysis and myotoxicity. Notably, cats have been reported to be about three times less sensitive 
(on a weight basis) to both brown and tiger snake venoms than dogs (Moisidis et al. 1996).  
 
Early studies by Kellaway, (Kellaway 1929, 1932, 1934) and more recently work by Harris et al., 
(Harris  et  al.  1975,  1981,  2000;  Preston  et  al.  1990)  and  others,  have  examined  the 
histopathological effects of Notechis sp. in envenomed animal tissue. In most of these studies the 
focus has been on the neurotoxic and myotoxic effects of this family of venoms and most involved 
the  examination of  experimentally  envenomed  animal  muscle tissue. Similarly,  Lewis,  (1994) 
(Lewis  1994),  examined  skeletal  muscle  tissue  of  experimentally  envenomed  dogs,  but  also 
extended  his  histopathological  analysis  to  the  kidney  looking  at  direct  nephrotoxic  effects  of 
N.scutatus venom. Although these studies have aided our understanding of the mechanisms of 
actions of some of these neuro- and myotoxins, more specifically, notexin, none have defined their 
specific tissue localisation. Moreover, none thus far have investigated the in vivo procoagulant 
effects of or described the histopathological changes in the heart and lung after Notechis species 
clinical envenomings. 
 
Numerous studies have looked into the direct effects of snake venom toxins based on clinical 
outcomes,  histopathological  changes  and  in  vitro  effects  on  cells.  Such  studies  include  the MANUSCRIPT
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measurement of various clinical indications, such as serum creatine kinase (CK), creatinine levels 
for myotoxic effects (Ponraj and Gopalakrishnakone 1997, 1996) and International Normalisation 
Ratio/ Prothrombin Time (INR/PT), Activated Partial Thromboplastin Time (APTT), D-Dimer 
levels  and  whole  blood  clotting  time  for  coagulopathic  envenomings  (Ferguson  et  al.  2002; 
Isbister et al. 2002, 2006). Testing of venoms in vitro on various animal derived primary and 
cultured  cells  (Hodgson  and  Wickramaratna  2002;  Kubo  et  al.  2002;  Kuruppu  et  al.  2006; 
Marshall  and  Herrmann  1989;  Rigoni  et  al.  2004)  and  on  animal  nerve-muscle  preparations 
(Ramasamy et al. 2004; Zamuner et al. 2004) have aided our understanding of mechanisms of 
action  and  toxicities,  while  others  observed  histopathological  changes  in  animal  tissues  after 
injection of venom or purified venom toxins (Mandal and Bhattacharyya 2007; Ponraj, 1997) to 
define sites and mechanisms of action. The majority of these studies have focused on snakes found 
outside Australia. Where these studies focused on the clinical outcomes and in vitro functions of 
various snake venoms and their toxins, others have measured crude venom levels in tissues and 
organs of experimental animals and human autopsy specimens (Brunda et al. 2006; Selvanayagam 
et al. 1999). No studies to date have detected or identified the specific tissue (cellular) localisation 
of Australian venom toxins in the tissues or organs of clinically envenomed patients. 
 
Venom toxins thought to be responsible for the most severe clinical effects seen in humans and 
domestic animals are: (i) prothrombin activating enzymes acting on coagulation factors leading to 
venom induced consumptive coagulopathy, (ii) pre and post-synaptic neurotoxins that result in 
paralysis and (iii) myotoxic components that promote muscle cell destruction (or myonecrosis). 
Therefore we might expect to find venom toxins localised on the endothelium of the vasculature, 
on neuronal cells and throughout muscle tissue respectively in envenomed patients. In the case of 
prothrombin activators, demonstration of a substantial amount of the toxin bound to endothelial 
surfaces would cause us to question the relevance of serum concentrations of this toxin as most of 
the active toxin may be on the endothelial surface rather than in the blood. The aims of this study 
were to examine clinically envenomed animal tissue for evidence of procoagulant, neurotoxic and 
myotoxic venom activity and to use a panel of developed antibodies to identify tissue specific 
toxin localisation. 
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2.  Materials and Methods 
2.1 Materials 
Antibodies:  mouse  anti-CD146  was  purchased  from  Abcam,  anti-mouse  FITC  and  anti-rabbit 
AF488  from  Millipore,  Streptavidin-Cy3,  Hoescht  3342  stain  and  Protein-G-Sepahrose  were 
obtained from Amersham Biosciences. SuperFrost slides (Ecco) and OCT embedding medium 
were purchased from ProSciTech, Perth. The SOLV solution (Xylene substitute) was purchased 
from Scot Scientific, Perth and foetal bovine serum (FBS) was purchased from Gibco. 
 
2.2 Samples 
Feline and Canine samples were obtained from two patients with Tiger snake envenoming whom 
presented  to  Murdoch  Pet  Emergency  Centre  (MPEC),  Murdoch  University  between  October 
2008 and March 2009. Ethics approval was obtained from Murdoch University (Ref: R2202/08) 
and The University of Western Australia (UWA) (Ref: F15811). Samples were collected with the 
owner’s consent. The species of snake responsible was, in both cases, determined by a venom 
detection kit (VDK), CSL Ltd from patient serum. Control canine and feline tissue was obtained 
from  non-envenomed  MPEC  patients  with  ethical  approval.  Mice  were  maintained  at  the 
Biomedical Research Facility, UWA (Ref: RA/100/593).   
 
2.3 Tissue collection and processing 
Within one hour of death, multiple biopsy samples were collected from the envenomed canine and 
feline patients. Tissues collected were lung, heart, kidney and Gastrocnemius muscle. One sample 
of each tissue was immediately frozen in OCT medium stepwise on liquid nitrogen and stored at -
80ºC. The second biopsy sample of each tissue was placed in 10% formalin and maintained at 
room temperature. Post mortem urine and serum samples were collected from  the canine and 
feline patients as part of their routine treatment. 
 
Frozen canine tissue was trimmed and sectioned (10μm) on a Leica Microtome (Model CM30505) 
and sections fixed to slides for 5 minutes in ice cold acetone. Fixed slides were then stored at -
80ºC. Segments of formalin fixed tissue (canine and feline) were oriented to obtain transverse 
sections  and immersed in  50% alcohol. Tissues  were processed and stained by the Histology 
Department  (Technologists  Michael  Slaven  and  Gerard  Spoelstra),  School  of  Veterinary  and 
Biomedical  Science,  Faculty  of  Health  Science,  Murdoch  University.  In  brief,  tissues  were MANUSCRIPT
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processed  on  a  Tissue  Tek  VIP  tissue  processor  and  dehydrated  with  changes  in  various 
concentrations of alcohol. Tissues were then embedded in paraffin using a Leica EG 1150C and 
4μm sections cut on a Leica microtome. All paraffin embedded tissue slides were stained with 
Haematoxylin and Eosin (H&E), Martius Scarlet Blue (MSB) and Periodic Acid Schiff (PAS). All 
tissue sections were examined by light microscopy.  
 
2.4 Immunohistochemistry 
Monoclonal and polyclonal (pAb) antibodies raised to detect Notechis scutatus venom (Nsv) and 
Notexin, both unconjugated and biotinylated, were optimised for use in Immunohistochemistry 
(IHC) using normal and frozen envenomed mouse tissue sections.. Each of the antibodies was 
tested at varying concentrations (1:50, 1:100 and 1:200). Similarly, secondary antibodies (anti-
mouse FITC, anti-rabbit AF488 and Streptavidin-Cy3) were titrated to determine optimal working 
dilutions. Prior to staining with antibodies, paraffin embedded tissue sections were deparaffinised 
and subjected to an antigen retrieval. This was accomplished by an initial immersion of the tissue 
sections  in  three  changes  of  SOLV  (Xylene  substitute)  solution  for  10  minutes.  Slides  were 
subsequently transferred into 100% alcohol (3 changes of 3 mins each) followed by 95%, 70% and 
50% ethanol respectively for 3 minutes each. Sections were rinsed twice with PBS (5 mins) and 
processed for antigen retrieval. Tissue sections were immersed in citrate buffer (10mM, pH 6.0) 
and incubated at 95ºC, 10 mins and allowed to cool for 20 minutes. Sections were washed in PBS 
and blocked with 10% FBS in PBS. Primary antibodies were then added and incubated overnight 
at 4°C in a humidified chamber. Relevant antibody controls were prepared for each tissue type. 
Tissue sections were washed with 2 changes of PBS (5 mins) followed by the application of 
secondary antibodies; anti-mouse FITC and Streptavidin-Cy3 required a further 1 hour incubation 
and two additional washes with PBS. The final wash contained a 1:5,000 dilution of Hoescht stain 
(Amersham) to enable the visualisation of the cell’s DNA. Slides were viewed on an inverted 
fluorescent microscope (Olympus, IX71) and images captured with an Olympus (DP70) camera. 
   MANUSCRIPT
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3.  Results 
3.1 Case Histories 
3.1.1 Case 1 
Collie cross Kelpie canine, 2 years old, Female; presented to MPEC in cardiac and respiratory 
arrest  within 2 hours of suspected envenoming. Upon presentation, the patient was  intubated, 
ventilated, followed by CPR. Despite drug administration (adrenaline, atropine and IV Hartman’s 
at shock rates) and 4 attempts at defibrillation, there was no response. The owners decided to halt 
CPR given the poor prognosis. A venom detection kit (VDK) was performed on post mortem 
serum which was strongly and immediately positive for Tiger snake venom. The circulating serum 
crude venom (Nsv) concentration (post mortem) was determined to be 22.5ng/ml and notexin 
level 11.1ng/ml by immunoassay. 
 
3.1.2 Case 2 
Domestic Shorthair feline, 1 year old, Male; presented to MPEC early in the morning after having 
appeared  normal  the  night  before.  On  initial  physical  examination,  the  patient  was  in  lateral 
recumbency with flaccid paralysis of all four limbs. There was generalised Lower Motor Neuron 
(LMN) paralysis, weak palpebral reflexes (eyelid/eyebrow), dilated pupils and absent pupillary 
light response (PLR). VDK on urine was strongly positive to Tiger snake venom. APPT was 75 
seconds (normal range of 60 to 115) and serum Creatine kinase (CK) was 93,800 U/L (normal 
range  of  50  to  100).  Symptoms  progressed  to  severe  LMN  paralysis  and  the  feline  became 
hypotensive,  hypothermic  and  hypoxic.  Urine  showed  signs  of  haemoglobinuria  and/or 
myoglobinuria.  Treatment  included  Chlorpheniramine  (1mg/kg)  IM  and  7  vials  of  antivenom 
(AV) which included 2 vials of Summerland Serums Tiger/Multibrown AV administered within 
15 minutes of the initial exam, a third vial 3 hours later, another vial 3 hours later and a further 3 
vials 7 hours after the first dose administered. Each Summerland Serums Tiger/Multibrown AV 
contains 3000 units Tiger snake AV plus 1500 units of Brown snake AV. At this stage the feline 
was  hypoventilating  (PvCO2  =  73mmHg,  and  ETCO2  =  60mmHg)  with  decreased  respiratory 
effort and rate, consistent with severe flaccid paralysis progressing to respiratory paralysis. At this 
point ventilation commenced. 
 
Flaccid  paralysis  remained  through  the  evening  and  the  patient  was  maintained  under  light 
anaesthesia with alfaxalone by continuous rate infusion (CRI). Mild improvement was seen the 
following  day,  with  the  feline  able  to  move  and  objecting  to  the  endotracheal  (ET)  tube  but 
displayed ongoing hypoventilation when attempting to wean from the ventilator. On day 3, CK MANUSCRIPT
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levels of 805,100 U/L, AST = 6,440 (normal range 26 to 43), ALT = 1,520 (normal range 0 to 83) 
with urea and creatine normal. Complete blood count (CBC) showed mild anaemia and a mild 
thrombocytosis/thrombocythaemia. Mild improvement in neurological status was observed and 
although the patient could maintain ETCO2 levels within normal ranges for up to 30 minutes, the 
patient quickly developed respiratory fatigue without ventilator support. On day 4, CK serum 
concentrations had decreased to 226,720 U/L, AST = 1,520 and ALT = 1,360. The feline went 
into  cardiac  arrest  during  an  ET  tube  change,  failed  to  respond  to  CPR/adrenaline  and 
subsequently passed away. Serum crude venom (Nsv) concentration (pre treatment) was found to 
be 28.7ng/ml. 
 
3.2 Histopathological Changes  
A summary of the tissue specific histopathological findings are presented in Table 1. Evidence of 
procoagulant venom effects were observed in the epicardium of the feline heart (Figure 1A and B) 
and throughout the feline pulmonary tissue (Figure 1C and E) as well as in the vasculature of the 
renal cortex in the canine patient (Figure 1F), apparent by visibly formed thrombi. The presence of 
fibrin was confirmed by MSB staining. The lungs of both animals showed multifocal to coalescing 
alveolar collapse, (Figure 2A and C), hence the lungs were unable to fully inflate, some of which 
may have been in part due to post-mortem changes. The presence of eosinophilic (proteinaceous) 
material  within the alveoli is  consistent  with  the presence of oedema and  small aggregate of 
fibrillar deposits possibly suggestive of further procoagulant venom activity, indicated by arrows 
in Figure 2C.   
 
Hydropic changes were observed in kidney tissue of both patients’, a degenerative change where 
cells  swell  with  fluid  was  observed,  indicative  of  cells  becoming  vacuolated.  No  signs  of 
proteinuria or necrosis were observed in the canine tissue; however, distinct changes indicating 
increased glomerular permeability were noted in the feline kidney. In the feline occasional fibrillar 
deposits were seen in the glomeruli; glomerular capillary thrombus formation may be indicative of 
procoagulant  toxin  activity.  Expanded  Bowman’s  spaces  containing  an  amorphous  pale 
eosinophilic material, confirmed by PAS staining, was suggestive of proteinuria (Figure 3B and 
C) in the feline tissue. The appearance of hypereosinophilic epithelial cells without the presence of 
an  accompanying  inflammatory  response  was  indicative  of  mild  post-mortem  autolysis.  No 
pathological changes were observed in the canine GM tissue, which was not surprising as the time 
since envenoming to presentation and death was within 3 hours, thereby not allowing the toxins 
sufficient time to reach the muscle fibres and cause myonecrosis. In contrast, significant changes MANUSCRIPT
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were  observed  in  the  feline  tissue  including  selective  degeneration  of  myofibres  with  an 
accompanying inflammatory response (Figure 4A and B); and as indicated by arrows in Figures 
4C  and  D,  macrophages  are  seen  actively  phagocytosing  individual  necrotic  myofibres.  Non-
envenomed feline muscle tissue is presented for comparison (Figure 4E and F) 
 
3.3  Tissue localisation of venom toxins 
Although  minor  histopathological  observations  were  made  in  both  cardiac  tissues,  modest 
fluorescence was apparent when staining the tissue with an anti-Nsv IgG pAb. Limited staining of 
frozen sections of the entire canine myocardium along with a speckled staining throughout the 
cardiac muscle tissue was seen when compared to the secondary alone control (not shown) and the 
non-envenomed tissue control. However, when probing the canine pulmonary tissue with the same 
pAb,  multifocal  to  coalescing  intense  staining  was  observed,  indicating  the  presence  of  a 
significant amount of venom in this tissue (Figure 5A and B). A commercially available anti-
CD146 antibody, reactive with endothelial cells and smooth muscle, also showed limited staining 
on  paraffin  embedded  tissue  and  so  it  was  difficult  to  determine  exactly  where  the  venom 
localised. As illustrated in Figure 5A and B, it appeared as though the toxins were not confined to 
one specific location (i.e. blood vessels, bronchi or bronchioles), but scattered throughout the 
tissue.  This  is  consistent  with  the  appearance  of  nerve  fibres,  to  be  confirmed  with  further 
investigation.  All  fluorescence  observed  was  absent  in  secondary  alone  controls  and  non-
envenomed tissue sections (Figure 5C and D). 
Correlating to histopathological changes observed in the feline kidney, IHC experiments carried 
out on frozen canine kidney tissue resulted in anti-Nsv staining in and around the glomerular 
capsule in the renal cortex, as well as in surrounding tubules (Figure 6A). No distinct staining 
above background fluorescence was observed in the feline kidney, which may be the result of a 
combination of the administration of antivenom, the time since envenoming and collection of the 
tissue  (>4  days),  as  opposed  to  the  canine  tissue,  which  was  collected  within  3  hours  post 
envenomation.  Although  it  may  have  been  too  early  following  envenomation  to  observe 
histopathological changes in the canine GM tissue, IHC assays revealed that venom was present. 
Illustrated in Figure 6D and E, using a biotinylated anti-Nsv (then Strep-Cy3), punctate staining 
pattern was observed in both patients through the Gastrocnemius muscle tissue itself as well as a 
staining of toxins within the vasculature (centre bottom bundle). All staining observed was greater 
than the fluorescence intensity of the secondary alone and non-envenomed control tissue (Figure 
6C and F) controls at the same exposure. MANUSCRIPT
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4.  Discussion 
The purpose of this work was to initially assess the histopathological changes in several organs of 
clinically envenomed tiger snake patients, confirmed by VDK, and relevant controls and secondly 
to conduct preliminary experiments to localise venom toxins in vivo. What become very clear 
through  this  work  is  that  histopathological  change  in  tissues  in  response  to  Australian  elapid 
envenoming is an area poorly represented in the literature.   
This work was conducted in consultation with an experienced Veterinary Specialist in Emergency 
Medicine  and  Critical  Care  plus  a  Pathologist  which  has  ensured  that  no  signs  commonly 
presenting in normal domestic animals have been misinterpreted as venom induced effects.  
4.1 Heart 
In the canine tissue, mild, peracute, multifocal haemorrhage was observed (not shown) which is 
consistent with findings reported by Tibballs et al. (Tibballs et al. 2002).  The canine heart tissue 
showed changes within a short time period (2 hours), therefore suggestive that the coagulopathic 
venom toxins are fast acting toxins, exerting their effects soon after envenoming. Although there 
were no signs of cardiac myocyte degeneration (indicative of myotoxic venom activity) in either 
patient’s  heart  tissue,  a  small  epicardial  thrombus  was  detected  in  the  feline  heart  sections, 
indicative of procoagulant toxin action.   
4.2 Lung 
The histopathological  changes  in  the lungs  of  both  pulmonary tissues  are  consistent  with  the 
clinical  outcomes  seen  in  both  patients.  Several  thrombi  were  observed  within  the  feline 
vasculature (Figure 1C-E) which would more than likely manifest clinically as dyspnoea. The 
feline had been ventilated for several days post envenoming and went into cardiac arrest when 
being weaned off the ventilator. It is likely that the venous thrombosis was directly caused by the 
original snake envenoming, but time spent on the ventilator may have contributed to the fibrinous 
alveolar exudates observed. The pulmonary thrombosis evident was sufficiently significant to be 
functionally catastrophic. Direct pathological thrombosis, more specifically pulmonary embolism 
as  a  result  of  snake  envenoming  has  only  previously  been  described  in  cases  involving  the 
Martinique vipers and related species from the West Indies (Dong-Zong et al. 2002; Thomas et al. 
1995).  MANUSCRIPT
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It has been suggested that in true coagulopathy a brief window of thrombus formation as the toxin 
enters the circulation is expected (White 2005), which prior to the activation of fibrinolysis gives 
rise to the consumption of coagulation factors, seen clinically in patients. Thrombus formation has 
previously  been  documented  in  experimental  dogs  in  response  to  brown  snake  envenoming 
(Tibballs et al. 1991, 1992). This work has also shown pulmonary thrombus formation as well as 
emboli observed in heart and kidney tissues. It has been suggested that even a few minutes of such 
thrombotic complications can be devastating for the victim, as the occlusion of critical vessels by 
thrombi can result in cardiac arrest and death (White 2005).  
4.3 Kidney 
Although Tiger snake envenoming has been widely reported to cause kidney damage in clinically 
envenomed patients (Cheng and Currie 2004; Currie 2000; Hood 1975; Jolles et al. 1998; White 
1995), it is unclear whether renal failure is a direct result of the venom’s nephrotoxicity or a 
secondary effect of myoglobinuria.  Different types of kidney damage induced by snake venoms 
and purified venom toxins (from snakes found outside Australia) has been thoroughly reviewed by 
Sitprija et al., (1982) (Sitprija et al. 1982), allowing us to utilise this work when examining kidney 
damage caused by Australian snakes. 
Interestingly, within the vasculature of the canine renal cortex, a small thrombus/embolus was 
observed (Figure 1F). Usually, thrombi are attached to the vascular endothelium, however, in this 
case it is possible that the thrombus detached from the endothelium as an embolus and was freely 
circulating through the patient’s vasculature. One particular study of the renal effects of tiger 
snake envenoming in experimental dogs showed the presence of lesions, indicating acute tubular 
necrosis (Lewis 1994). The author also noted the presence of variable amounts of proteinaceous 
material  within  the  renal  tubules.  Our  work  is  consistent  with  these  findings  where  mild 
proteinuria was observed within the proximal loops of Henle and the Bowmans’s space of the 
feline kidney. This is indicative of increased glomerular permeability and is suggestive of direct 
toxin activity. In the canine kidney, anti-Nsv staining showed a punctuate fluorescence pattern in 
and around the glomerulus and surrounding tubules suggesting large amounts of venom are being 
filtered through the kidneys most likely leading to the renal damage identified. 
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4.4 Muscle 
The  effects  of  tiger  snake  phospholipase  A2  myotoxins  on  muscle  fibres  have  been  well 
documented  and  shown  to  produce  skeletal  muscle  paralysis  by  inhibiting  synaptosomal 
membrane choline transport from nerve endings (Mollier et al. 1990). Harris et al.  (Harris et al. 
1975, 2003; Harris and MacDonell 1981; White 1987) showed that the purified notexin caused 
destruction of the myofibres in a mosaic pattern and Preston et al., (1990) (Preston et al. 1990) 
found a dose-dependent relationship between the extent of muscle loss and the amount of venom 
injected  in  experimental  animals.  The  feline  muscle  tissue  in  this  study  also  clearly  showed 
myotoxicity with an inflammatory response as defined by Mebs and Ownby, (1990) (Mebs and 
Ownby 1990) and Harris and Maltin (Harris and Maltin 1982), respectively. 
No signs of necrosis were observed in the canine muscle which may be due to the short time frame 
between envenoming and presentation, as opposed to the feline.  Lewis, (1994) (Lewis, 1994) 
found  that  after  the  injection  of  N.scutatus  venom  into  the  muscle  tissue  of  dogs,  segmental 
necrosis of the underlying tissue within 1 hr of envenomation was present and the degeneration of 
myofibres at 3 hrs post bite. A major difference here is that the toxin was delivered locally and 
directly to the musculature rather than through the circulation as in the clinical patients described 
here.  
In the canine GM muscle, although no histopathological changes were observed, a clear staining 
pattern was observed. This staining was consistent with the histopathological changes observed in 
the  feline  muscle.  Venom  staining  in  the  canine  appeared  the  brightest  in  several  locations 
throughout  the  connective  tissue  between  muscle  epimysium  with  many  less  bright  areas 
appearing  in  the  endomysium  (shown  to  contain  capillaries)  and  within  the  muscle  fibres 
themselves. Although not as prominent as in the canine, a mild scattered staining pattern was 
observed in the feline muscle (not shown). Considering the myonecrosis observed in the feline 
muscle by standard histopathological examination, it is not surprising that venom was detected 
within the tissue.  
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Concluding remarks 
In this work it was not anticipated that venom would be detected in the feline tissues as this patient 
had been treated with 7 vials of antivenom and therefore venom toxins would more than likely 
already  be  bound  by  antibody  molecules.  In  the  canine  patient  however,  envenoming  and 
presentation was within 2 hours, with no antivenom treatment and we therefore anticipated venom 
toxins to be abundant in the canine tissue, which coincides with our results. . 
This work has described the examination of post mortem heart, lung, kidney and Gastrocnemius 
muscle tissue from two tiger snake envenomed animal patients admitted to MPEC. For the first 
time, pathological evidence of procoagulant venom activity has been presented, with numerous 
thrombi  observed  in  the  lungs,  heart  and  kidney  of  the  clinically  envenomed  patients.  This 
supports the proposal that an initial thrombotic state occurs in snakebite patients that leads to the 
depletion of vital clotting factors, manifesting in VICC, clinically seen in human and domestic 
animal  victims.  A  panel  of  antibodies  has  been  developed  against  various  Australian  snake 
venoms and individual toxins for use in localising venom toxins in vivo in envenomed patient 
tissue.  Results  presented  here  suggest  the  presence  of  venom  toxins  in  each  of  the  tissues 
examined and offer a valuable tool in further clarifying toxin localisation.  
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Table 1: Histopathological findings of analysed tiger snake envenomed domestic animal tissue MANUSCRIPT
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Figure 1 Histopathological evidence of procoagulant venom activity in clinically envenomed animal tissue. A. Feline cardiac tissue, x200, 
MSB stained. Myocardium (Myo) on the left and Subepicardial adipose tissue   (Ep) to the right containing coronary arteries (CA) and vein (CV) 
surrounded by muscular connective tissue (collagen stains blue). The vein (top right) contains an early thrombus, B. Feline cardiac tissue, x 400, MSB 
stained. A higher magnification of the thrombus inside the vascular lumen (VL), C. Feline pulmonary tissue, x100, H&E stained. Notice the thickening of 
the alveolar septa (a) and the thrombi (Thr) in the smaller blood vessels (BV), D. Feline pulmonary tissue, x 200, MSB stained. Large bronchus (Br) filled 
with eosinophilic material surrounded by Hyaline cartilage (Hc). Above bronchus is a large blood vessel lumen (BVL) containing a large early thrombus, 
E. x400, MSB stained. Large thrombus in large muscular artery magnified further and composed of erythrocytes (yellow), leukocytes (nuclei brown/black) 
and fibrin (red/pink) and clusters of platelets appearing amphophilic (pink/purple), F. Canine kidney, x100, MSB stained. Observe the renal cortex blood 
vessel containing a small thrombus formation (red). MANUSCRIPT
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Figure 2 Histopathological changes in envenomed and non-envenomed pulmonary tissue. A. Canine tissue, x100, MSB stained. Notice 
the  general  congestion  and  a  blood  vessel  (BV)  filled  with  erythrocytes  (yellow)  and  two  bronchi  (BR)  filled  with  eosinophilic 
(proteinaceous) material and the presence of extravascular erythrocytes, indicative of haemorrhage, B. Canine tissue, x200, MSB stained. 
Notice hyperaemia (pooling of erythrocytes within the vasculature) within the alveolar septa and alveolar atelectasis (collapse). Also apparent 
is the proteinaceous, lacy material present in the bronchioles (Br), C. Feline tissue, x 200, MSB stained. Observe multifocal small aggregates 
of red fibrillar deposits throughout the alveolar septa and occasionally in the alveolar lumen, indicated by arrows, D. x100 and E. x200 Non-
envenomed Canine tissue, MSB stained and F. x100, Non-envenomed Feline tissue, MSB stained. MANUSCRIPT
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Figure 3 Histopathological observations of tiger snake envenomed feline kidney tissue. A. 
x400, MSB stained. Notice the irregularly shaped glomeruli (GL) with expanded Bowman’s 
space (Bs) filled with eosinophilic (proteinaceous) material. Arrows indicate fibrillar deposits 
(bright red). Proximal convoluted tubules (PT), distal convoluted tubules (DT) and collecting 
tubules (CT) indicated, B. x200, PAS stained and C. x400, PAS stained. Notice occasional 
minor  proteinuria  indicated  by  lacy  material  in  the  proximal  loops  of  Henle  (PL)  and 
Bowman’s space (arrows), D. Non-envenomed feline glomerulus, MSB stained, x 200. 
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Figure 4 Histopathological observations of tiger snake envenomed Feline  
Gastrocnemius muscle tissue. A. x100, MSB stained. Notice the scattering of necrotic 
muscle fibres highlighted in blue/purple, B. x200, H&E stained. Muscle fibres with 
moderate inflammatory infiltrate, C. x200 and D. x400, MSB stained, both showing 
individual and grouped necrotic fibres and inflammatory infiltrate. All arrows indicate 
the presence of individual macrophages phagocytosing necrotic muscle fibres. E. x 200, 
H&E  stained,  non-envenomed  feline  muscle  and  F.  x  200,  MSB  stained  non-
envenomed feline muscle. 
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Figure 5 Anti-Nsv staining of tiger snake envenomed and non-envenomed canine lung tissue. Formalin fixed post-mortem pulmonary tissue 
was processed and embedded in paraffin. Sections were stained with an anti-Notechis scutatus pAb (left) and Hoechst stain, a merged image is 
presented (centre). A. and B. offer two distinct fields of view at x 400 magnification. Notice the antibody staining (red) and cell nuclei (blue). C. 
Non-envenomed canine lung, x 200, stained with anti-NsPA/Strep-Cy3 and D. Hoescht stained non-envenomed canine lung, x 200. MANUSCRIPT
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Figure 6 Anti-Nsv staining of tiger snake envenomed canine kidney and muscle tissue. x400. A. Renal tissue stained with anti-Nsv pAb 
followed by anti-rabbit AF488. Notice areas of bright staining in and around the glomerulus (GL) and surrounding tubules. Bowman’s space 
(Bs) is also indicated. B. Hoechst stain and C. anti-rabbit AF488 secondary alone control. D. GM tissue, x200, stained with anti-Nsv pAb 
Biotin followed by Streptavidin-Cy3. Notice the bundle of cellular material within the vascular endothelium as well as punctate staining 
throughout the muscle tissue. E. Hoechst stain and F. x100, Non-envenomed canine muscle tissue stained with anti-Nsv pAb Biotin followed 
by Streptavidin-Cy3. MANUSCRIPT
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